MolGenDia Sp. z o.o. is a dynamic company at the forefront of biotechnology research, specializing in innovative technologies related to personalized medicine and oncology in Poland. With core competencies in molecular diagnostics and genetic research, MolGenDia serves as a key distributor of comprehensive genetic testing services, including advanced molecular profiling utilizing gene expression information based on microarray technology.
MolGenDia's commitment to advancing healthcare is evident in its comprehensive offerings tailored to meet the specific needs of patients, medical centers, laboratories, and molecular biology and pathomorphology labs with genetic or molecular biology focuses. Located at ul. Marii Konopnickiej 15, Bydgoszcz, 85-124, PL, MolGenDia is dedicated to delivering cutting-edge solutions that drive precision medicine and improve patient outcomes.
Through its unwavering dedication to innovation and quality, MolGenDia Sp. z o.o. is well-positioned to make significant contributions to the fields of biotechnology and personalized healthcare. We invite the management of MolGenDia to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and reach.
Compare MolGenDia Sp. z o.o. with 3 companies in Biotechnology-Research
| Comparison Field |
MolGenDia Sp. z o.o.Main Company |
GeneDxView Profile |
Journal of "Artifici...View Profile |
Inside Precision Med...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2021 | 2014 |
|
Company Size
|
— | 1,001-5,000 | 11-50 | 51-200 |
|
City
|
Stamford, CT | NY, New Rochelle | ||
|
Country
|
United States | |||
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Molecular Diagnostics
Personalized Medicine
Oncology
Genetic Research
Biotechnology
Molecular Profiling
Precision Medicine
molecular diagnostics
personalized medicine
personalized oncology
Theranostics
Precision medicine
genetic testing
|
9 Total
9 Unique
Unique Skills:
artificial intelligence
exome
genetics
genome
neonatal screening
next generation sequencing
+3
|
20 Total
20 Unique
Unique Skills:
Ai
AI technologies
Artificial Intelligence
biomarker identification
Clinical
computer vision
+14
|
3 Total
3 Unique
Unique Skills:
information
news
precision medicine
|
Other organizations in the same industry
This company is also known as